1. Metagenomic analysis identified microbiome alterations and pathological association between intestinal microbiota and polycystic ovary syndrome
    Weiwei Chu et al, 2020, Fertility and Sterility CrossRef
  2. The Implication of Mechanistic Approaches and the Role of the Microbiome in Polycystic Ovary Syndrome (PCOS): A Review
    Anirban Goutam Mukherjee et al, 2023, Metabolites CrossRef
  3. Recent updates on animal models for understanding the etiopathogenesis of polycystic ovarian syndrome
    Leander Corrie et al, 2021, Life Sciences CrossRef
  4. Low-dose spironolactone attenuates metabolic defects in the skeletal muscle of letrozole-induced hyperandrogenic female rats
    Stephanie E. Areloegbe et al, 2023, Nutrire CrossRef
  5. تأثير هرمونات الغدة الدرقية وفيتامين د والسكر التراكمي على متلازمة تكيس المبايض (Polycystic Ovary Syndrome (PCO
    Imhemed O. Fiedan et al, 2024, Journal of the Academic Forum CrossRef
  6. INTERDISCIPLINARY CLINICAL PRACTICE GUIDELINES "MANAGEMENT OF OBESITY AND ITS COMORBIDITIES"
    I. I. Dedov et al, 2021, Obesity and metabolism CrossRef
  7. Correlation Between Fecal Metabolomics and Gut Microbiota in Obesity and Polycystic Ovary Syndrome
    Ling Zhou et al, 2020, Frontiers in Endocrinology CrossRef
  8. Endoplasmic reticulum stress-mediated ferroptosis in granulosa cells contributes to follicular dysfunction of polycystic ovary syndrome driven by hyperandrogenism
    Huimin Ding et al, 2024, Reproductive BioMedicine Online CrossRef
  9. Proteomic sift through serum and endometrium profiles unraveled signature proteins associated with subdued fertility and dampened endometrial receptivity in women with polycystic ovary syndrome
    Nadia Rashid et al, 2020, Cell and Tissue Research CrossRef

  10. Polycystic Ovary Syndrome and Pelvic Floor Dysfunction: A Narrative Review


    Marzieh Saei Ghare Naz et al, 2020, Research and Reports in Urology CrossRef
  11. Predictive Value of Homeostasis Model Assessment of Insulin Resistance, Visceral Fat Index, and Prepregnancy Body Mass Index in Gestational Metabolic Syndrome
    Laiping Zhao et al, 2021, Evidence-Based Complementary and Alternative Medicine CrossRef
  12. Relevance of KISS1 gene polymorphisms in susceptibility to polycystic ovary syndrome and its associated endocrine and metabolic disturbances
    MH Daghestani et al, 2020, British Journal of Biomedical Science CrossRef
  13. Functional and endocrine-metabolic oligomenorrhea: proposal of a new diagnostic assessment tool for differential diagnosis in adolescence
    Silvia Baggio et al, 2019, Journal of Pediatric Endocrinology and Metabolism CrossRef
  14. Development and Evaluation of Curcumin Encapsulated Self-assembled Nanoparticles as Potential Remedial Treatment for PCOS in a Female Rat Model
    Mazhar Ali Raja et al, 2021, International Journal of Nanomedicine CrossRef
  15. Omega-3 supplementation in the treatment of polycystic ovary syndrome (PCOS) – a review of clinical trials and cohort
    Vitoria Melo et al, 2022, Endocrine Regulations CrossRef
  16. Prevalence of PCOD in Patients Visiting OPD of Karuna Medical College
    Harrini K et al, 2020, Journal of Evolution of Medical and Dental Sciences CrossRef
  17. The Prevalence of Gestational Diabetes Mellitus in Polycystic Ovary Disease—A Systematic Review, Meta-Analysis, and Exploration of Associated Risk Factors
    Rajani Dube et al, 2024, Diabetology CrossRef
  18. Pathophysiological changes in experimental polycystic ovary syndrome in female albino rats: Using either hemin or L‐arginine
    Merhan M. Ragy et al, 2019, Journal of Cellular Physiology CrossRef
  19. Association of Luteinizing hormone and LH receptor gene polymorphism with susceptibility of Polycystic ovary syndrome
    Ritu Deswal et al, 2019, Systems Biology in Reproductive Medicine CrossRef
  20. The Ameliorating Effects of Bushen Huatan Granules and Kunling Wan on Polycystic Ovary Syndrome Induced by Dehydroepiandrosterone in Rats
    Yang Xu et al, 2021, Frontiers in Physiology CrossRef
  21. Autophagy in ovary and polycystic ovary syndrome: role, dispute and future perspective
    Sanjana Kumariya et al, 2021, Autophagy CrossRef
  22. Individual and combined effects of 5-year exposure to hyperandrogenemia and Western-style diet on metabolism and reproduction in female rhesus macaques
    Cecily V Bishop et al, 2021, Human Reproduction CrossRef
  23. Hyperandrogenism drives ovarian inflammation and pyroptosis: A possible pathogenesis of PCOS follicular dysplasia
    Yu Xiang et al, 2023, International Immunopharmacology CrossRef
  24. Very low dose spironolactone protects experimentally-induced polycystic ovarian syndrome from insulin-resistant metabolic disturbances by suppressing elevated circulating testosterone
    Oluwaseun A. Adeyanju et al, 2019, Chemico-Biological Interactions CrossRef
  25. Letrozole treatment of pubertal female mice results in activational effects on reproduction, metabolism and the gut microbiome
    Pablo Arroyo et al, 2019, PLOS ONE CrossRef
  26. Synergistic Effects of Hyperandrogenemia and Obesogenic Western-style Diet on Transcription and DNA Methylation in Visceral Adipose Tissue of Nonhuman Primates
    Lucia Carbone et al, 2019, Scientific Reports CrossRef
  27. Exploration of hub genes involved in PCOS using biological informatics methods
    Fei Zhou et al, 2022, Medicine CrossRef
  28. Long-Term Metabolic Consequences in Patients with a History of Gestational Diabetes
    Eleni Kousta et al, 2020, Current Pharmaceutical Design CrossRef
  29. Prevalence and Dietary Management of Polycystic Ovary Syndrome among Libyan Women Attending in Infertility Center Tripoli, Libya
    Noor AL-Hoda Ben-Issa et al, 2024, AlQalam Journal of Medical and Applied Sciences CrossRef
  30. Inter-relationship between polycystic ovary syndrome and metabolic syndrome
    Mohd Ashraf Ganie et al, 2024, Metabolic Syndrome CrossRef
  31. Circulating microparticles as indicators of cardiometabolic risk in PCOS
    Banafsheh Yalameha et al, 2022, Clinica Chimica Acta CrossRef
  32. Research Progress on the Relationship between Polycystic Ovary Syndrome and Metabolic Syndrome Components
    亚倩 王, 2024, Medical Diagnosis CrossRef
  33. Emerging role of GIP and related gut hormones in fertility and PCOS
    R. Charlotte Moffett et al, 2020, Peptides CrossRef
  34. Effect of healthy lifestyle promotion on anthropometric variables, eating behavior and cardiometabolic risk factors in women with polycystic ovarian syndrome
    Latifa Imen Benharrat et al, 2020, The North African Journal of Food and Nutrition Research CrossRef
  35. Mogroside V Improves Follicular Development and Ovulation in Young-Adult PCOS Rats Induced by Letrozole and High-Fat Diet Through Promoting Glycolysis
    Lan’e Huang et al, 2022, Frontiers in Endocrinology CrossRef
  36. Acetate mitigates cardiac mitochondrial dysfunction in experimental model of polycystic ovarian syndrome by modulating GPCR41/43 and PROKR1
    Stephanie E. Areloegbe et al, 2023, Biochemical and Biophysical Research Communications CrossRef
  37. Insulin Therapy in Pregnancy Hypertensive Diseases and its Effect on the Offspring and Mother Later in Life
    Alfonso Mate et al, 2019, Current Vascular Pharmacology CrossRef
  38. Association of Pregnancy Outcome Complications Among Females with Polycystic Ovary Syndrome
    Laiba Tariq et al, 2022, DIET FACTOR (Journal of Nutritional & Food Sciences) CrossRef